I don't just rant about methods and evidence -- in my work life I also rant about health economics and outcomes! This is why I was so interested in this post by the health economist Ulf Staginnus called"New Models for Market Access." I want to give a hat tip to Healtheconomics.com for pointing me here. The thesis of the article is that we need to refocus our discussion from market access to true innovation in the biopharma sector. There are some...
Thursday, 22 December 2011
Tuesday, 13 December 2011
When end of life is not
Twenty years ago, I helped save a man's life.So begins this New York Times essay by Peter Bach, MD, where he talks about the inadequacy of resource use at the end of life as a policy metric. Now, I am not very fond of policy metrics, as most of you know. So, imagine my surprise when I found myself disagreeing vehemently with Peter's argument. Well, to be fair, I did not disagree with him completely. I only disagreed with the thesis that he constructed,...
